1 - 4 out of 4Page size: 10
  1. 2026

  2. Cyclophosphamide-Mediated Induction of Myeloid-Derived Suppressor Cells In Vivo: Kinetics of Accumulation, Immune Profile, and Immunomodulation by Oleanane-Type Triterpenoids

    Awad, M. S., Sen’kova, A. V., Markov, A. V., Salomatina, O. V., Zenkova, M. A. & Markov, O. V., 6 Jan 2026, In: International Journal of Molecular Sciences. 27, 2, 32 p., 564.

    Research output: Contribution to journal › Article › peer-review

  3. 2025

  4. Reversing the Irreversible: miRNA-Targeting Mesyl Phosphoramidate Oligonucleotides Restore Sensitivity to Cisplatin and Doxorubicin of KB-8-5 Epidermoid Carcinoma Cells

    Miroshnichenko, S., Demirel, R., Moralev, A., Almieva, O., Markov, A., Burakova, E., Stetsenko, D., Maslov, M., Vlassov, V. & Zenkova, M., 18 Dec 2025, In: Biomedicines. 13, 12, 26 p., 3118.

    Research output: Contribution to journal › Article › peer-review

  5. Soloxolone N-3-(Dimethylamino)propylamide Suppresses Tumor Growth and Mitigates Doxorubicin-Induced Hepatotoxicity in RLS40 Lymphosarcoma-Bearing Mice

    Moralev, A. D., Sen'kova, A. V., Firsova, A. A., Solomina, D. E., Rogachev, A. D., Salomatina, O. V., Salakhutdinov, N. F., Zenkova, M. A. & Markov, A. V., 10 Dec 2025, In: International Journal of Molecular Sciences. 26, 24, 24 p., 11912.

    Research output: Contribution to journal › Article › peer-review

  6. Synthesis and exploration of anticancer potential of spirocyclic 1,2,3-triazoline and aziridine derivatives of natural eudesmanolide isoalantolactone

    Patrushev, S. S., Kichkina, D. O., Moralev, A. D., Rybalova, T. V., Krasnov, V. I., Chernyak, E. I., Zenkova, M. A., Markov, A. V. & Shults, E. E., Feb 2025, In: Bioorganic Chemistry. 155, 24 p., 108124.

    Research output: Contribution to journal › Article › peer-review

ID: 59657314